UPDATE: Piper Sandler Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Tweet Send to a Friend
(Updated - August 12, 2022 5:21 AM EDT)
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Lexicon Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Lexicon Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
